Longitudinal muscle development is not significantly disturbed in Vrp1f06715/Vrp1D30 transheterozygote embryos.
Homozygous embryos show defects in myoblast fusion.
Vrp1f06715 and Vrp1f06715/Df(2R)ED3943 mutants display a severe embryonic somatic muscle phenotype with strong muscle fusion defects.
In the visceral mesoderm of Vrp1f06715 embryos the founder cells and the fusion competent myoblasts appear to fuse despite the absence of Vrp1. The visceral mesoderm of Vrp1f06715 mutants appears slightly disorganised at early stages, however the development of the gut proceeds, and Vrp1f06715 mutants develop a gut structure with midgut constrictions at later stages.
At stage 12, in both Vrp1f06715 and control embryos the longitudinal muscles surround the circular musculature, and at later stage, both in mutants and controls, the longitudinal muscles form a characteristic longitudinal pattern, indicating that longitudinal muscle development is not affected in Vrp1f06715 mutants.
Some myoblast fusion takes place in Vrp1f06715 mutants, but growing myotubes are still surrounded by numerous unfused myoblasts at the end of embryogenesis.
Vrp1f06715 has embryonic myoblast phenotype, enhanceable by dock04723
Vrp1f06715 has embryonic myoblast phenotype, enhanceable by WASp3
Vrp1f06715 has myoblast | embryonic stage phenotype, enhanceable by SCARΔ37
Vrp1f06715 has plasma membrane | embryonic stage phenotype, enhanceable by SCARΔ37
Vrp1f06715 is a non-suppressor of visceral mesoderm phenotype of Alk10
Vrp1f06715 is a non-suppressor of embryonic myoblast phenotype of Alk10
SCARΔ37, Vrp1f06715 has longitudinal visceral muscle primordium phenotype
SCARΔ37, Vrp1f06715 has embryonic/larval gut | embryonic stage phenotype
SCARΔ37, Vrp1f06715/Vrp1[+] has embryonic/larval midgut longitudinal visceral muscle cell | embryonic stage phenotype
SCARΔ37/SCAR[+], Vrp1f06715 has embryonic/larval midgut longitudinal visceral muscle cell | embryonic stage phenotype
SCARΔ37;Vrp1f06715 double homozygous mutant embryos show normal gut constriction but aberrant morphology. Longitudinal visceral muscle founder cells show aberrant migration and severe muscle fusion defects are observed: mostly mononucleated and binucleated muscle cells are seen at late embryonic stages. These defects are weaker in SCARΔ37/SCARΔ37;Vrp1f06715/+ embryos (founder cell migration mostly normal though fusion defects are still observed) and not much improved in SCARΔ37/+;Vrp1f06715/Vrp1f06715 embryos (both founder cell migration and muscle fusion defects observed).
dock04723 enhances the myoblast fusion defects seen in Vrp1f06715 embryos.
WASp3 enhances the myoblast fusion defects seen in Vrp1f06715 embryos.
Loss of Vrp1 through a Vrp1f06715 mutant background does not affect fusion in Alk10 mutants, as mutant cells of the visceral mesoderm are able to both migrate and fuse with cells of the somatic mesoderm.
SCARΔ37 Vrp1f06715 double mutants exhibit a dramatically increased myoblast-fusion defect compared to the single mutants.
Vrp1f06715 is rescued by Scer\GAL4sns.PS/Vrp1UAS.fl.Tag:MYC
Vrp1f06715 is rescued by Scer\GAL4twi.PG/Vrp1UAS.fl.Tag:MYC
Vrp1f06715 is rescued by Scer\GAL4sns.PS/Vrp1Δ2xWH2.UAS.Tag:MYC
Vrp1f06715 is rescued by Scer\GAL4twi.PG/Vrp1Δ2xWH2.UAS.Tag:MYC
Vrp1f06715 is not rescued by Scer\GAL4sns.PS/Vrp1ΔProΔWBD.UAS.Tag:MYC
Vrp1f06715 is not rescued by Scer\GAL4twi.PG/Vrp1ΔProΔWBD.UAS.Tag:MYC
Vrp1f06715 is not rescued by Scer\GAL4sns.PS/Vrp1ΔWBD.UAS.Tag:MYC
Vrp1f06715 is not rescued by Scer\GAL4twi.PG/Vrp1ΔWBD.UAS.Tag:MYC
Expression of Vrp1Scer\UAS.fl.T:Hsap\MYC in fusion-competent myoblasts under the control of Scer\GAL4sns.PS fully rescues the muscle fusion defects found in Vrp1f06715 mutants.
Expression of Vrp1Scer\UAS.fl.T:Hsap\MYC in muscle cells under the control of Scer\GAL4twi.PG fully rescues the muscle fusion defects found in Vrp1f06715 mutants.
Expression of Vrp1Δ2xWH2.Scer\UAS.T:Hsap\MYC in fusion-competent myoblasts under the control of Scer\GAL4sns.PS fully rescues the muscle fusion defects found in Vrp1f06715 mutants.
Expression of Vrp1Δ2xWH2.Scer\UAS.T:Hsap\MYC in muscle cells under the control of Scer\GAL4twi.PG fully rescues the muscle fusion defects found in Vrp1f06715 mutants.